First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?

Código QR

First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?

The development of antiangiogenic treatments, followed by immune checkpoint inhibitors (ICI), has significantly changed the management of metastatic clear cell renal cell cancer. Several phase III trials show the superiority of combination therapy, dual immunotherapy (ICI-ICI) or ICI plus tyrosine k...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yann-Alexandre Vano, Sylvain Ladoire, Réza Elaidi, Slimane Dermeche, Jean-Christophe Eymard, Sabrina Falkowski, Marine Gross-Goupil, Gabriel Malouf, Bérangère Narciso, Christophe Sajous, Sophie Tartas, Eric Voog, Alain Ravaud
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	metastatic clear cell renal cell carcinoma first-line treatment immunotherapy tyrosine kinase inhibitors combinations Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/becd57d4d59b43458af2ace5bd8612ce
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Leptin and Leptin Receptor are Expressed only in Clear Cells of Rat Epididymis Epithelia
por: Gombar,Flavia Meireles, et al.
Publicado: (2017)

Metastatic melanoma with sebocyte-like melanocytes and widespread visceral involvement
por: Li-Wei Chang, et al.
Publicado: (2020)

Clinical Experience with Apatinib and Camrelizumab in Advance Clear Cell Sarcoma: A Retrospective Study
por: Wang J, et al.
Publicado: (2021)

Giant clear cell acanthoma with dermatoscopic white lines
por: Omid Zargari, et al.
Publicado: (2018)

Diagnostic and prognostic value of placental growth factor serum concentration in clear cell renal cell carcinoma
por: Marcela Cechova, et al.
Publicado: (2021)

Myoepithelial Carcinoma Spindle cell type, Clear cell type, and Plasmacytoid type: Serial Kasus A Case Series of Myoepithelial Carcinoma Spindle cell type, Clear cell type, and Plasmacytoid type
por: Dian Yuliartha Lestari, et al.
Publicado: (2018)

Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
por: Lu Zhang, et al.
Publicado: (2021)

Clear Cell Acanthoma With Melanophages Simulating a Spitz Nevus
por: Thaís Andrade De Oliveira, et al.
Publicado: (2021)

Identification TRIM46 as a Potential Biomarker and Therapeutic Target for Clear Cell Renal Cell Carcinoma Through Comprehensive Bioinformatics Analyses
por: Xiang-bin Ren, et al.
Publicado: (2021)

Identification of a Novel Stem Cell Subtype for Clear Cell Renal Cell Carcinoma Based on Stem Cell Gene Profiling
por: Hongzhi Wang, et al.
Publicado: (2021)

Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma
por: Myung-Chul Kim, et al.
Publicado: (2021)

Upregulation of TMEM45A Promoted the Progression of Clear Cell Renal Cell Carcinoma in vitro
por: Jiang H, et al.
Publicado: (2021)

Integrative Analysis of Immune-Related Genes in the Tumor Microenvironment of Renal Clear Cell Carcinoma and Renal Papillary Cell Carcinoma
por: Bin Zheng, et al.
Publicado: (2021)

Lipid rafts: cell surface platforms for T cell signaling
por: MAGEE,TONY, et al.
Publicado: (2002)

Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics
por: Wen Li, et al.
Publicado: (2021)

The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis
por: Yadi Zhou, et al.
Publicado: (2021)

Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma
por: Aimin Jiang, et al.
Publicado: (2021)

Integrated analysis on the N6‐methyladenosine‐related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma
por: Yuqin Qiu, et al.
Publicado: (2021)

Analysis and verification of N6-methyladenosine-modified genes as novel biomarkers for clear cell renal cell carcinoma
por: Zhenyu Yang, et al.
Publicado: (2021)

LINC02532 Contributes to Radiosensitivity in Clear Cell Renal Cell Carcinoma through the miR-654-5p/YY1 Axis
por: Xiaoguang Zhou, et al.
Publicado: (2021)

Characteristics of contrast‐enhanced ultrasound for diagnosis of solid clear cell renal cell carcinomas ≤4 cm: A meta‐analysis
por: Yang Liu, et al.
Publicado: (2021)

Prognostic value and immunological role of AXL gene in clear cell renal cell carcinoma associated with identifying LncRNA/RBP/AXL mRNA networks
por: Yi Wang, et al.
Publicado: (2021)

A CT-Based Radiomics Nomogram Integrated With Clinic-Radiological Features for Preoperatively Predicting WHO/ISUP Grade of Clear Cell Renal Cell Carcinoma
por: Yingjie Xv, et al.
Publicado: (2021)

Role of Endocytosis Proteins in Gefitinib-Mediated EGFR Internalisation in Glioma Cells
por: Elisabete Cruz Da Silva, et al.
Publicado: (2021)

Identification of CCL4 as an Immune-Related Prognostic Biomarker Associated With Tumor Proliferation and the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma
por: Lu Zhang, et al.
Publicado: (2021)

Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in 27 Cases
por: Zhiyang Zhang, et al.
Publicado: (2021)

Identification of the Prognostic Value Among Suppressor Of Cytokine Signaling Family Members in Kidney Renal Clear Cell Carcinoma
por: Changjiu Li, et al.
Publicado: (2021)

Microenvironment-associated gene HSD11B1 may serve as a prognostic biomarker in clear cell renal cell carcinoma: a study based on TCGA, RT‑qPCR, Western blotting, and immunohistochemistry
por: Di Han, et al.
Publicado: (2021)

Regulatory Functions of Protein Tyrosine Phosphatase Receptor Type O in Immune Cells
por: Feiling Xie, et al.
Publicado: (2021)

Machine learning-based CT radiomics approach for predicting WHO/ISUP nuclear grade of clear cell renal cell carcinoma: an exploratory and comparative study
por: Yingjie Xv, et al.
Publicado: (2021)

Histological Tracking into the Third Dimension: Evolution of Early Tumorigenesis in VHL Kidney
por: Mayyan Mubarak, et al.
Publicado: (2021)

Construction of circRNA‐based ceRNA network and its prognosis‐associated subnet of clear cell renal cell carcinoma
por: Yuwei Zhang, et al.
Publicado: (2021)

Antiangiogenic Properties of Axitinib versus Sorafenib Following Sunitinib Resistance in Human Endothelial Cells—A View towards Second Line Renal Cell Carcinoma Treatment
por: Eva Juengel, et al.
Publicado: (2021)

Ibrutinib protects T cells in patients with CLL from proliferation-induced senescence
por: Joanne E. Davis, et al.
Publicado: (2021)

The Potential of Visceral Adipose Tissue in Distinguishing Clear Cell Renal Cell Carcinoma from Renal Angiomyolipoma with Minimal Fat
por: Liu J, et al.
Publicado: (2021)

The Effect of Cytoreductive Partial Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma
por: Chen J, et al.
Publicado: (2020)

A methylomics-correlated nomogram predicts the recurrence free survival risk of kidney renal clear cell carcinoma
por: Xiuxian Zhu, et al.
Publicado: (2021)

Mixture of Kerosene and Xylene: a Contribution to Clearing Agents
por: Ofusori,David A, et al.
Publicado: (2009)

Tolerability and outcome of sunitinib by giving 4/2 schedule versus 2/1 schedule in metastatic renal cell carcinoma patients: a prospective randomized multi-centric Egyptian study
por: Lobna A. Abdelaziz, et al.
Publicado: (2021)

RHBDF2 gene functions are correlated to facilitated renal clear cell carcinoma progression
por: Lei Wang, et al.
Publicado: (2021)